NEW YORK , July 21, 2025 /PRNewswire/ -- Year-to-date, Overland Advantage ("Overland"), a business development company (BDC) with a differentiated direct lending approach that benefits from a strategic relationship between Centerbridge Partners and Wells Fargo & Company ("Wells Fargo"), financed nine new transactions, arranging capital with an aggregate value of $2.0 billion. Through solutions provided by Overland and Wells Fargo, companies secured unique, flexible and cost-effective financing solutions to help advance their strategic objectives alongside supportive banking products from Wells Fargo.

- Provides equipment that protects workers across industrial, commercial, and office spaces - PORT WASHINGTON, NY / ACCESS Newswire / July 21, 2025 / Global Industrial Company (NYSE:GIC), a value-added national distributor of industrial equipment and supplies, will be exhibiting at ASSP Safety 2025, the premier annual gathering for occupational safety and health professionals, taking place July 22-24 at Orange County Convention Center (West Building) in Orlando, FL. Global Industrial will be exhibiting at Booth #2115, showcasing a range of commercial- and industrial-grade solutions designed to enhance workplace safety, compliance, and operational efficiency across industrial, construction, and commercial environments.

UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that its Board of Directors has unanimously authorized the Company's executive team to explore a potential reverse merger transaction with a digital asset-focused operating company to supplement its existing businesses. The Board has also approved a strategic treasury initiative involving the acquisition and long-term holding of select digital assets, including Bitcoin.

FDA designation highlights the potential of PMN310 to deliver a more targeted approach to treating Alzheimer's Disease CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies targeting toxic misfolded proteins in neurodegenerative diseases, such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PMN310, the Company's lead therapeutic candidate in development for the treatment of Alzheimer's disease (AD).

HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU” or the “Company”), a KOL-driven online fashion and lifestyle destination in China, today announced its unaudited financial results for the six months ended March 31, 2025 and fiscal year 2025. Mr. Fan Yiming, Chief Executive Officer of MOGU, commented, “In the second half of fiscal year 2025, the platform continued to face challenges with the lifecycle of key opinion leaders (KOLs), which led to MOGU's gross merchandise value (GMV.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that management will host a conference call to discuss its second quarter 2025 financial results and provide a business update on Wednesday, August 6, 2025, at 8:00am ET. To access the live conference call, participants.

PARSIPPANY, N.J.--(BUSINESS WIRE)--Imagine this. You've just landed. Instead of wandering through a crowded parking garage or waiting for a shuttle, a welcome message pops up through your Avis app. By the time you reach the airport exit, your personal concierge is curbside with your premium vehicle. The cabin is cool, and your concierge helps you connect your CarPlay. No lines. No stress. Just the open road and a luxury experience that starts before you even put the car in drive. After you've c.

Upexi purchased an additional 100,000 SOL, and anticipates it may generate up to approximately $26 million in annual staking revenue based on current SOL holdings Company releases adjusted metrics for enhanced transparency and analysis

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today that it has been granted orphan drug designation by the European Medicines Agency (EMA) Committee, who adopted a positive opinion on KRRO-110, Korro's investigational medicine for the treatment of Alpha-1 Antitrypsin Deficiency (AATD).

Healthcare REITs have outperformed major indices, but several are now trading at significant premiums to fair value, warranting caution. This article takes a quick look at 5 such companies, with a thumbnail sketch and 9 key metrics. Despite strong growth prospects for some, high price/FFO ratios, elevated premiums to NAV, and dividend safety concerns make these REITs questionable at current prices.

Enrollment in FURVENT was completed in Q1 2025 Firmonertinib received FDA Breakthrough Therapy Designation in this patient population NEWTOWN SQUARE, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that topline firmonertinib monotherapy data from the global pivotal FURVENT Phase 3 (NCT05607550) study in first-line EGFR exon20 insertion mutant non-small cell lung cancer (NSCLC) is projected to be in early 2026.

New York, New York--(Newsfile Corp. - July 21, 2025) - Aeries Technology (NASDAQ: AERT), a global leader in AI-enabled value creation, business transformation, and Global Capability Center (GCC) delivery for private equity portfolio companies, today announced the launch of its AI Partner Network Program . This initiative brings together a select set of agentic AI-native solutions curated to meet the operational needs of mid-market companies backed by private equity.

London, United Kingdom--(Newsfile Corp. - July 21, 2025) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), today announced that it has resolved its previously disclosed litigation against Culper Research ("Culper") and its founder, Christian Lamarco. The Company issued the following statement: Subsequent to a report published on April 4, 2025 by Culper Research, Gorilla Technology filed a lawsuit against Culper and its founder, Christian Lamarco, on April 16, 2025.

GLEN ALLEN, Va.--(BUSINESS WIRE)--Dynex Capital, Inc. ("Dynex" or the "Company") (NYSE: DX) reported its second quarter 2025 financial results today. Management will host a call today at 10:00 a.m. Eastern Time to discuss the results and business outlook. Details to access the call can be found below under "Earnings Conference Call." Second Quarter Financial Performance and Other Highlights Total economic loss of $(0.10) per common share, or (0.8)% of beginning book value, comprised of a declin.

MCLEAN, Va.--(BUSINESS WIRE)---- $BAH--Booz Allen Hamilton (NYSE: BAH) announced that it is tripling its venture capital commitment from $100 million to $300 million.

PHOENIX--(BUSINESS WIRE)--Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced the winners of the 30th Annual ‘FLIR Vision Awards' at the APSCON 2025 Conference in Phoenix, Arizona. The FLIR Vision Awards are presented to members of the airborne law enforcement community who have best demonstrated use of thermal imaging systems in carrying out their missions, whether conducting search and rescue efforts, pursuing suspects, or saving lives in other ways. The aw.

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported revenue year-over-year. Bruker estimates that its non-GAAP organic revenue in the second quarter of 2025 declined approximately 7% year-over-year, with constant-exchange rate revenue declining approximately 3%. Second quarter 2025 bookings reflect weak academic demand, as w.

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE: PBI), a technology-driven products and services company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the world – including more than 90 percent of the Fortune 500 – today announced that it will report second quarter 2025 earnings results after market close on Wednesday, July 30, 2025. The Company will host an investor conference call at 5:00 p.m. ET on the same day to review its res.

Seasoned Compliance Leader Joins Bitcoin Depot to Support Global Expansion and Strengthen Regulatory Strategy Seasoned Compliance Leader Joins Bitcoin Depot to Support Global Expansion and Strengthen Regulatory Strategy

ATCHISON, Kan.--(BUSINESS WIRE)--MGP Ingredients, Inc. (Nasdaq:MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, announced the company's Board of Directors has appointed Julie Francis as President and Chief Executive Officer of MGP, effective today. It is anticipated that Francis will join the MGP Board at the 2026 Annual Meeting of Stockholders. Brandon Gall, who has served as Interim President and Chief Executive Officer since January 1, 2025, will cont.